about
Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptomsAripiprazole versus haloperidol for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus sulpiride for people with schizophrenia and schizophrenia-like psychosesAripiprazole versus perphenazine for people with schizophrenia and schizophrenia-like psychosesLithium for schizophreniaHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersIncreasing antipsychotic dose for non response in schizophreniaIncreasing antipsychotic dose versus switching antipsychotic for non response in schizophreniaAcetophenazine versus chlorpromazine for schizophreniaSwitching antipsychotic for non response in schizophreniaElectroconvulsive therapy for treatment-resistant schizophreniaHaloperidol discontinuation for schizophreniaMirtazapine (adjunct) versus placebo for schizophreniaPerphenazine versus low-potency first-generation antipsychotic drugs for schizophreniaFlupenthixol versus low-potency first-generation antipsychotic drugs for schizophreniaFluphenazine versus low-potency first-generation antipsychotic drugs for schizophreniaCarbamazepine for schizophreniaHaloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaTrifluoperazine versus low-potency first-generation antipsychotic drugs for schizophreniaBenzodiazepines for schizophreniaMaintenance treatment with antipsychotic drugs for schizophreniaHaloperidol versus first generation antipsychotics for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaPerazine for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaQuetiapine versus other atypical antipsychotics for schizophreniaFluphenazine (oral) versus atypical antipsychotics for schizophreniaZotepine versus other atypical antipsychotics for schizophreniaRisperidone versus other atypical antipsychotics for schizophreniaFlupenthixol versus low-potency first generation antipsychotic drugs for schizophreniaFluphenazine versus low-potency first generation antipsychotic drugs for schizophreniaHaloperidol versus low-potency first-generation antipsychotic drugs for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaPerphenazine versus low-potency first generation antipsychotic drugs for schizophreniaTrifluoperazine versus low-potency first generation antipsychotic drugs for schizophreniaAripiprazole versus other atypical antipsychotics for schizophreniaZiprasidone versus other atypical antipsychotics for schizophreniaAmisulpride versus other atypical antipsychotics for schizophreniaZotepine versus other atypical antipsychotics for schizophrenia
P2860
Q22242835-02CA08CA-E88C-4306-AC58-A1F93D7D2A4FQ24186218-061771BE-6E49-4429-9B28-BF5E830FD4CDQ24186219-AB5C438E-E685-4189-8EE0-188C4EF4F6B2Q24186220-2751AC77-0081-4A68-9331-14480B9BD074Q24186223-D51B1C34-1476-4383-83AD-73815DD8FDA1Q24186325-FFE42C9B-9224-4C8F-88CB-E643BEB50BF0Q24186601-0FEA32B3-E897-42E5-91FF-9B324874E755Q24186768-9761CC8B-CD43-45B4-BAFD-23071A3BC9E9Q24186772-5A7B8D5D-3995-4079-A29B-B668EEF71760Q24186800-EB2E0EC6-B372-4E3B-AFFD-1692B664736DQ24187478-E762B062-E5DF-4640-959B-91853AB5E2D4Q24187594-D75A86C0-70E4-4525-BBCC-3CA18D2482C2Q24187607-16031CF6-63DA-4FDC-9C27-88C4702E7DD9Q24188248-09C97B56-961A-486F-AE6D-B794F9E4CE80Q24193168-B2609B38-DEF1-45AE-97E6-B3B53F161D18Q24193881-F0069B62-C0DA-4ECE-A54D-95B7D9BEAB79Q24194501-E053B9B1-3C02-4F33-A7B0-03A3C949BB6AQ24194779-855CAB7A-CBDA-44F0-8F4A-F270A40F2FAFQ24194891-4A2CA62E-A40B-43C0-8397-5EC13BF6B52AQ24194898-A266F06E-863A-43E1-AFA9-49F46D72647BQ24197501-05501583-F6A7-4E64-9E0B-D22FC7F71BF3Q24197902-5981D58A-682E-4C11-A707-EC1BDA800216Q24198264-848BDDE3-3824-413D-B722-0A378BD8DA09Q24200904-2BD48BB4-86CA-4706-B08C-0FD59B0D2B5FQ24201125-3F25C61B-F5B9-478B-AC0D-32DC23226D1AQ24201232-21205C77-E3D2-420A-8BF8-1E4D602FE163Q24202427-055351B0-18B4-4FE7-914C-3A527195471CQ24202712-154BF16D-27EE-4D78-93B5-64644E799477Q24234683-99881E78-6FB9-42B6-A6DF-9B45B255BDDDQ24234950-64010C78-F818-46C9-BDC8-979A34C5A9D0Q24235116-93AD3ECE-67FC-4CF8-B780-EDD2409AACC9Q24235274-09A02C94-FFCA-4343-B609-53C273F85805Q24235300-E74C9A76-A02B-41B2-9FF6-DB5420D45001Q24236545-782496D0-5F22-4244-807D-C9B597F0EC52Q24236586-81294133-4C82-4B5C-935A-70D5468D41AFQ24236681-6C4CE9E3-4849-488C-B1BE-51C37DE2EB29Q24240020-7C0134F3-8817-4B1C-933C-4CDF34ED18C1Q24240260-89A1395F-EA31-414E-8776-DBF0965B0E4FQ24240433-A5D02CD3-077D-4D8F-9066-A10AC36A2D3DQ24240500-81136018-87E7-4DEE-A37A-A745253345F4
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Schizophrenia and employment - a review.
@ast
Schizophrenia and employment - a review.
@en
type
label
Schizophrenia and employment - a review.
@ast
Schizophrenia and employment - a review.
@en
prefLabel
Schizophrenia and employment - a review.
@ast
Schizophrenia and employment - a review.
@en
P1476
Schizophrenia and employment - a review.
@en
P304
P356
10.1007/S00127-004-0762-4
P577
2004-05-01T00:00:00Z